Evidence map›Paper›PMID 30762747›Full record

ArticleMedicine2019

High concentrations of serum interleukin-6 and interleukin-8 in patients with bipolar disorder.

Yun-Rong Lu, Ying-Bo Rao, Yu-Jian Mou, Yan Chen, Han-Fen Lou, Yu Zhang, Dan-Xuan Zhang, Hai-Yan Xie, Li-Wei Hu, Ping Fang

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Dopamine, Immunity, and Disease.Pharmacological reviews · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yun-Rong LuDepartment of Psychiatry, The Fourth Affiliated Hospital, Zhejiang University, School of Medicine, Yiwu.
Ying-Bo RaoDepartment of Clinical Laboratory, The Fourth Affiliated Hospital, Zhejiang University, School of Medicine, Yiwu, Zhejiang, China.
Yu-Jian MouDepartment of Psychiatry, The Fourth Affiliated Hospital, Zhejiang University, School of Medicine, Yiwu.
Yan ChenDepartment of Psychiatry, The Fourth Affiliated Hospital, Zhejiang University, School of Medicine, Yiwu.
Han-Fen LouDepartment of Psychiatry, The Fourth Affiliated Hospital, Zhejiang University, School of Medicine, Yiwu.
Yu ZhangDepartment of Psychiatry, The Fourth Affiliated Hospital, Zhejiang University, School of Medicine, Yiwu.
Dan-Xuan ZhangDepartment of Psychiatry, The Fourth Affiliated Hospital, Zhejiang University, School of Medicine, Yiwu.
Hai-Yan XieDepartment of Psychiatry, The Fourth Affiliated Hospital, Zhejiang University, School of Medicine, Yiwu.
Li-Wei HuDepartment of Psychiatry, The Fourth Affiliated Hospital, Zhejiang University, School of Medicine, Yiwu.
Ping FangDepartment of Psychiatry, The Fourth Affiliated Hospital, Zhejiang University, School of Medicine, Yiwu.
Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune system dysregulation plays a key role in the physiopathology of bipolar disorder (BD) and major depressive disorder (MDD). However, whether interleukins might be biomarkers to distinguish these 2 affective disorders is unclear. Here, we assessed the differences in serum levels of interleukin 6 (IL-6) and interleukin 8 (IL-8) as well as C-reactive protein (CRP) in patients with MDD and BD. In total, we enrolled 21 MDD patients, 26 BD patients, and 20 healthy controls. We collected a total of 35 samples from BD patients in 3 different phases, depression phase, manic phase, and remission stage, and 27 samples from MDD patients in acute and remission phases. Serum IL-6 and IL-8 levels were assessed with solid phase sandwich ELISA-based quantitative arrays, and CRP levels were determined with an automatic analyzer. Both serum IL-6 and IL-8 levels were elevated in BD patients but not MDD patients. Subgroup analysis indicated elevated serum IL-6 in both the depression and manic phases in BD patients. The serum CRP levels did not change in either BD or MDD patients. However, sex differences in CRP concentrations were observed in healthy controls. Furthermore, there were linear correlations between the CRP levels and Bech-Rafaelsen Mania Rating Scale (BRMS) scores in BD patients. IL-6 and IL-8 levels may serve as biomarkers to differentiate between MDD and BD patients, even when the clinical manifestations are atypical. IL-6 may be used for the differential diagnosis of MDD and depressive episodes in BD.

Indexed as

AdultBiomarkersBipolar DisorderCase-Control StudiesC-Reactive ProteinFemaleHumansInterleukin-6Interleukin-8Longitudinal StudiesMajor Depressive DisorderMaleRetrospective StudiesSex FactorsBiomarkersC-Reactive ProteinCXCL8 protein, humanIL6 protein, humanInterleukin-6Interleukin-8

Identifiers

PMID30762747
PMCPMC6407988
OpenAlexW2911269100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.